215
POSTERS AND ELECTRONIC POSTERS
| PROGRAMME AND EXHIBITION GUIDE
ELECTRONIC POSTERS
> Primary (chemo)radiation therapy in organ-sparing treatment of tongue
squamous cell carcinoma
A. Gevorkov (Russian Federation), A. Boyko
EP-1062
> Patient reported voice outcomes after laser surgery or radiotherapy for
T1 laryngeal cancer
R. Simcock (UK), D. Walker, A. Addison, M. Harries
EP-1063
> Reirradiation results in head and neck tumours
L. Gutierrez Bayard (Spain), M. Salas Buzón, L. De Ingunza Barón,
S. Garduño Sánchez, E. González Calvo, I. Villanego Beltrán, V. Díaz Díaz,
L. Díaz Gómez
EP-1064
> Post-treatment FDG-PET CT in detecting residual disease in head &
neck squamous cell carcinoma
J. Price (UK), A. Pascoe, C. Weston,
S. Kathirgamakarthigeyan, M. Griffin, R. Ganatra, J. Christian
EP-1065
> Low FDG-PET detection rate of the primary tumor for patients with
cervical lymph node metastases
E. Dale (Norway), J.M. Moan, T.V. Bogsrud
EP-1066
> Assessing the outcome in 3D and IMRT head and neck (H&N) cancer
patients: are we doing well?
I. Prieto (Spain), J. Luna, J. Olivera, J. Vara, A. Perez
EP-1067
> Impact of pretreatment primary tumor volume on survival of patient
with T4a larynx cancer
A. Mohamed, J. Shiao (USA), J. Messer, W. Morrison, M. Zafereo, A. Hessel,
S. Lai, M. Kies, R. Ferrarotto, A. Garden, R. Weber, D. Rosenthal,
C.D. Fuller
EP-1068
> Nasopharyngeal carcinoma screening by plasma EBV DNA and serum
antibodies in an outpatient clinic
C.W. Twu (Taiwan), J. Jin-Ching Lin, W. Wen-Yi Wang
EP-1069
> Prognostic role of FDG-PET performed before or during radiotherapy
in head and neck cancer
M. Min (Australia), P. Lin, M. Lee, I. Ho Shon, M. Lin, D. Forstner,
M.T. Tieu, A. Chicco, V. Bray, A. Fowler
EP-1070
> Maintenance metronomic chemotherapy for recurrent/metastatic
nasopharyngeal carcinoma
C. Wu (Taiwan), W.Y. Wang, C.W. Twu, P.J. Lin, Y.C. Liu, J.C. Lin
EP-1071